Allient (ALNT) Competitors $24.64 +0.22 (+0.90%) Closing price 02/4/2025 04:00 PM EasternExtended Trading$24.64 0.00 (0.00%) As of 02/4/2025 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ALNT vs. TRNS, CTKB, BNGO, SENS, LAB, EYPT, QTRX, AEHR, QSI, and NAUTShould you be buying Allient stock or one of its competitors? The main competitors of Allient include Transcat (TRNS), Cytek Biosciences (CTKB), Bionano Genomics (BNGO), Senseonics (SENS), Standard BioTools (LAB), EyePoint Pharmaceuticals (EYPT), Quanterix (QTRX), Aehr Test Systems (AEHR), Quantum-Si (QSI), and Nautilus Biotechnology (NAUT). These companies are all part of the "measuring and control equipment" industry. Allient vs. Transcat Cytek Biosciences Bionano Genomics Senseonics Standard BioTools EyePoint Pharmaceuticals Quanterix Aehr Test Systems Quantum-Si Nautilus Biotechnology Transcat (NASDAQ:TRNS) and Allient (NASDAQ:ALNT) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, community ranking, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Do institutionals and insiders hold more shares of TRNS or ALNT? 98.3% of Transcat shares are owned by institutional investors. Comparatively, 61.6% of Allient shares are owned by institutional investors. 2.3% of Transcat shares are owned by company insiders. Comparatively, 15.6% of Allient shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is TRNS or ALNT more profitable? Transcat has a net margin of 6.22% compared to Allient's net margin of 2.64%. Allient's return on equity of 10.80% beat Transcat's return on equity.Company Net Margins Return on Equity Return on Assets Transcat6.22% 7.43% 6.01% Allient 2.64%10.80%4.75% Does the MarketBeat Community believe in TRNS or ALNT? Transcat received 207 more outperform votes than Allient when rated by MarketBeat users. However, 66.67% of users gave Allient an outperform vote while only 66.14% of users gave Transcat an outperform vote. CompanyUnderperformOutperformTranscatOutperform Votes21166.14% Underperform Votes10833.86% AllientOutperform Votes466.67% Underperform Votes233.33% Does the media prefer TRNS or ALNT? In the previous week, Transcat had 27 more articles in the media than Allient. MarketBeat recorded 30 mentions for Transcat and 3 mentions for Allient. Allient's average media sentiment score of 0.80 beat Transcat's score of 0.32 indicating that Allient is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Transcat 5 Very Positive mention(s) 6 Positive mention(s) 4 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Neutral Allient 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, TRNS or ALNT? Allient has higher revenue and earnings than Transcat. Allient is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTranscat$259.48M2.81$13.65M$1.8542.86Allient$578.63M0.72$24.10M$0.8828.00 Do analysts rate TRNS or ALNT? Transcat currently has a consensus target price of $111.50, suggesting a potential upside of 40.61%. Allient has a consensus target price of $29.33, suggesting a potential upside of 19.05%. Given Transcat's higher probable upside, analysts clearly believe Transcat is more favorable than Allient.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Transcat 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40Allient 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more risk and volatility, TRNS or ALNT? Transcat has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Comparatively, Allient has a beta of 1.61, meaning that its share price is 61% more volatile than the S&P 500. SummaryTranscat beats Allient on 9 of the 17 factors compared between the two stocks. Get Allient News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALNT vs. The Competition Export to ExcelMetricAllientInstruments to measure electricity IndustryComputer SectorNASDAQ ExchangeMarket Cap$414.94M$4.62B$26.50B$9.11BDividend Yield0.48%0.44%2.73%4.00%P/E Ratio28.0023.23238.0018.31Price / Sales0.722.713,199.3081.15Price / Cash6.5118.3736.2333.55Price / Book1.594.178.634.76Net Income$24.10M$144.73M$676.40M$223.10M7 Day Performance-3.41%0.10%0.39%0.18%1 Month Performance-3.79%-9.55%-0.36%-1.98%1 Year Performance-10.89%3.61%27.55%23.41% Allient Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALNTAllient4.2464 of 5 stars$24.64+0.9%$29.33+19.0%-14.0%$414.94M$578.63M28.002,287Positive NewsGap DownTRNSTranscat3.6106 of 5 stars$99.31-0.2%$130.25+31.2%-29.8%$913.65M$259.48M50.161,104CTKBCytek Biosciences1.2118 of 5 stars$5.73-0.2%$9.25+61.4%-31.2%$738.09M$201.21M-71.62500Short Interest ↓BNGOBionano Genomics2.5737 of 5 stars$5.82-20.2%$90.00+1,446.4%-92.6%$680.47M$36.12M-2.51300Short Interest ↑SENSSenseonics2.6725 of 5 stars$1.06-6.2%$2.00+88.7%+68.5%$631.05M$22.39M-8.1590LABStandard BioTools3.1562 of 5 stars$1.57-4.8%$2.88+83.1%-39.9%$584.45M$155.90M-2.21620EYPTEyePoint Pharmaceuticals1.6573 of 5 stars$8.02-6.0%$26.63+232.0%-73.4%$547.37M$46.02M-4.01120Short Interest ↑QTRXQuanterix2.7147 of 5 stars$9.58+0.1%$23.25+142.7%-63.5%$369.02M$122.37M-9.04460AEHRAehr Test Systems3.2783 of 5 stars$11.88-4.3%$25.00+110.4%-26.4%$352.96M$66.22M15.8490Gap DownQSIQuantum-Si2.6707 of 5 stars$2.21-3.9%$3.25+47.1%+27.0%$315.40M$2.27M-3.45150Gap UpNAUTNautilus Biotechnology2.6495 of 5 stars$1.84-4.2%$3.58+94.7%-35.6%$231.04MN/A-3.29130 Related Companies and Tools Related Companies Transcat Alternatives Cytek Biosciences Alternatives Bionano Genomics Alternatives Senseonics Alternatives Standard BioTools Alternatives EyePoint Pharmaceuticals Alternatives Quanterix Alternatives Aehr Test Systems Alternatives Quantum-Si Alternatives Nautilus Biotechnology Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ALNT) was last updated on 2/5/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNew crypto boom will be greatest in historyUrgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is t...Banyan Hill Publishing | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allient Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allient With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.